Posted in | News | Medical Robotics

Preventice Clears FDA for Commercializing BodyGuardian Remote Monitoring System

Preventice has declared that it has received 510(k) clearance for its BodyGuardian Remote Monitoring System (RMS) from the U.S. Food and Drug Administration (FDA).

Jointly developed with Mayo Clinic, the BodyGuardian System is based on advanced algorithms that enable remote monitoring of patients with cardiac arrhythmias. Using BodyGuardian System, medical experts can track key biometrics when the patient is external to the clinical setting. By fastening a small body sensor onto the patient's chest, key data such as the patient's activity level, ECG, heart rate, and respiration rate can be collected. Using mobile phone technology, patient data can be conveyed to physicians. Remote patient monitoring strengthens the bond between patients and their medical team.

Following the achievement of FDA clearance, Preventice can commercialize BodyGuardian to clinics, hospitals and medical centers for adoption to detect and track non-lethal cardiac arrhythmias in ambulatory patients. The BodyGuardian RMS is yet to be commercially available but can be recommended by qualified physicians for specific diagnostic and post-procedure monitoring. The BodyGuardian RMS will be commercially available by 2012 end.

There is rapid implementation of wireless monitoring. A recent research study from Berg Insight states that around 2.2 M global patients have been estimated to be using this type of technology. Berg's industry analysts hope increase in the adoption of wireless monitoring to attain 4.9 M by 2016. Furthermore, Technavio anticipates global patient monitoring market to reach $9.3 B by 2014.

BodyGuardian RMS is built on the Preventice Care Platform, which is a cloud-based mHealth platform that is capable of gathering real-time data from devices and providing information to medical monitoring experts worldwide.

Source: http://www.preventice.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaur, Kalwinder. (2019, February 20). Preventice Clears FDA for Commercializing BodyGuardian Remote Monitoring System. AZoRobotics. Retrieved on November 28, 2021 from https://www.azorobotics.com/News.aspx?newsID=3202.

  • MLA

    Kaur, Kalwinder. "Preventice Clears FDA for Commercializing BodyGuardian Remote Monitoring System". AZoRobotics. 28 November 2021. <https://www.azorobotics.com/News.aspx?newsID=3202>.

  • Chicago

    Kaur, Kalwinder. "Preventice Clears FDA for Commercializing BodyGuardian Remote Monitoring System". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3202. (accessed November 28, 2021).

  • Harvard

    Kaur, Kalwinder. 2019. Preventice Clears FDA for Commercializing BodyGuardian Remote Monitoring System. AZoRobotics, viewed 28 November 2021, https://www.azorobotics.com/News.aspx?newsID=3202.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit